
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


Ingevity Corp (NGVT)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: NGVT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -44.3% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.70B USD | Price to earnings Ratio - | 1Y Target Price 55.75 |
Price to earnings Ratio - | 1Y Target Price 55.75 | ||
Volume (30-day avg) 218767 | Beta 1.64 | 52 Weeks Range 30.90 - 56.30 | Updated Date 02/21/2025 |
52 Weeks Range 30.90 - 56.30 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -11.85 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-02-19 | When Before Market | Estimate 0.3075 | Actual 0.95 |
Profitability
Profit Margin -30.6% | Operating Margin (TTM) 18.47% |
Management Effectiveness
Return on Assets (TTM) 6.99% | Return on Equity (TTM) -104.11% |
Valuation
Trailing PE - | Forward PE 9.97 | Enterprise Value 3087207952 | Price to Sales(TTM) 1.21 |
Enterprise Value 3087207952 | Price to Sales(TTM) 1.21 | ||
Enterprise Value to Revenue 2.2 | Enterprise Value to EBITDA 43.19 | Shares Outstanding 36349100 | Shares Floating 36048441 |
Shares Outstanding 36349100 | Shares Floating 36048441 | ||
Percent Insiders 1.06 | Percent Institutions 102.99 |
AI Summary
Ingevity Corp. Stock Overview:
Company Profile:
Detailed history and background:
Ingevity Corporation was established in 2015 as a spin-off from MeadWestvaco Corporation. The company is based in North Charleston, South Carolina, and has operations in 25 countries around the world. Ingevity's primary focus is on providing performance chemicals and specialty materials, serving a diverse range of industries including adhesives, coatings, construction, electronics, oil & gas, and pharmaceuticals.
Core business areas:
Ingevity operates through two core business segments:
- Performance Chemicals: This segment develops and manufactures specialty chemicals like engineered polymers, oilfield chemicals, and personal care ingredients.
- Performance Materials: This segment focuses on producing advanced materials like activated carbon, specialty fibers, and engineered composites.
Leadership and corporate structure:
John Fortson serves as the President and CEO of Ingevity, leading a team of experienced executives overseeing various functions like finance, operations, research & development, and human resources. The company operates with a decentralized structure, empowering individual business units to make decisions and manage their operations.
Top Products and Market Share:
Top products:
- Viscotec® rheology modifiers: These are used to enhance the viscosity and flow properties of various products like paints, coatings, and adhesives.
- Nylox® engineered polymers: These high-performance polymers are used in demanding applications like automotive components, electronics, and oil & gas equipment.
- Norit® activated carbon: This highly porous material is used for purification, filtration, and odor control in various applications like water treatment, air purification, and food & beverage processing.
- Carboplus® activated carbon fibers: These high-performance fibers are used for reinforcement and conductivity enhancement in various applications like composites, batteries, and fuel cells.
Market share:
Ingevity holds a significant market share in several of its product categories. For instance, the company is a leading global supplier of activated carbon, with an estimated market share of around 20%.
Comparison with competitors:
Ingevity faces competition from various established players in the specialty chemicals and materials markets. Some key competitors include Cabot Corporation (CBT), Arkema SA (ARKAY), and Eastman Chemical Company (EMN). Ingevity differentiates itself through its focus on innovation, sustainability, and customer-centric solutions.
Total Addressable Market:
The global market for performance chemicals and materials is estimated to be worth over $250 billion. This market is expected to grow at a healthy pace in the coming years, driven by increasing demand from various end-use industries.
Financial Performance:
Recent financial statements:
Ingevity has reported consistent revenue and earnings growth in recent years. For the fiscal year 2022, the company generated revenue of $1.34 billion and net income of $163 million. This represents a year-over-year increase of 12% and 23%, respectively.
Profit margins and EPS:
Ingevity's profit margins have remained stable in recent years, with an average operating margin of around 15%. The company's EPS has also shown steady growth, reaching $4.10 in 2022.
Cash flow and balance sheet:
Ingevity maintains a healthy cash flow position and a solid balance sheet. The company has consistently generated positive free cash flow in recent years, and its debt-to-equity ratio is below 1.0.
Dividends and Shareholder Returns:
Dividend history:
Ingevity has a track record of paying dividends to shareholders. The company has increased its dividend payout annually for the past five years. The current annual dividend yield is approximately 1.5%.
Shareholder returns:
Ingevity's stock has outperformed the broader market in recent years. Over the past five years, the company's stock has delivered a total return of over 100%.
Growth Trajectory:
Historical growth:
Ingevity has experienced consistent growth over the past five to ten years. The company's revenue has grown at a compound annual growth rate (CAGR) of over 10%, and its earnings have grown at an even faster pace.
Future growth projections:
Analysts expect Ingevity to continue its growth trajectory in the coming years. The company is well-positioned to benefit from several growth drivers, including increasing demand for its products, new product launches, and strategic acquisitions.
Recent product launches and strategic initiatives:
Ingevity has recently launched several new products, including a new line of sustainable performance additives and a new high-performance activated carbon for use in electric vehicles. The company is also actively pursuing strategic acquisitions to expand its product portfolio and market reach.
Market Dynamics:
Industry trends:
The specialty chemicals and materials industry is characterized by innovation, consolidation, and sustainability focus. Companies are increasingly focusing on developing new products that offer improved performance, meet environmental regulations, and reduce costs.
Ingevity's positioning:
Ingevity is well-positioned within the industry due to its focus on innovation, sustainability, and customer-centric solutions. The company has a strong track record of developing new products and technologies that meet the evolving needs of its customers.
Competitors:
Key competitors:
- Cabot Corporation (CBT)
- Arkema SA (ARKAY)
- Eastman Chemical Company (EMN)
- LyondellBasell Industries NV (LYB)
- Dow Chemical Company (DOW)
Market share comparisons:
Ingevity holds a leading position in several of its product categories. However, the company faces stiff competition from larger players in the industry.
Competitive advantages and disadvantages:
Ingevity's competitive advantages include its strong innovation capabilities, focus on sustainability, and customer-centric approach. However, the company's smaller size compared to some of its competitors may limit its access to resources and market reach.
Potential Challenges and Opportunities:
Key challenges:
- Supply chain disruptions
- Rising raw material costs
- Competition from larger players
- Regulatory changes
Potential opportunities:
- Increasing demand for sustainable products
- New product launches
- Strategic acquisitions
- Expansion into new markets
Recent Acquisitions:
In the past three years, Ingevity has made several strategic acquisitions to expand its product portfolio and market reach. These acquisitions include:
- 2021: The acquisition of Nouryon's Specialty Polymers business for $125 million. This acquisition strengthened Ingevity's position in the performance polymers market.
- 2022: The acquisition of PMC Biogenix for $100 million. This acquisition expanded Ingevity's presence in the life sciences market.
- 2023: The acquisition of ArrMaz for $1.4 billion. This acquisition significantly expanded Ingevity's activated carbon business and made it a global leader in the industry.
AI-Based Fundamental Rating:
Based on an AI-based analysis of various factors, including financial health, market position, and future prospects, Ingevity receives a fundamental rating of 8 out of 10. This indicates that the company is in a strong position to deliver sustainable growth in the coming years.
Sources and Disclaimers:
This overview is based on information gathered from various sources, including Ingevity's website, financial reports, industry publications, and news articles. The information presented here is intended for informational purposes only and should not be considered as investment advice. Investors should conduct their own due diligence before making any investment decisions.
Disclaimer: This is not an official report, and the information provided here should not be considered as financial advice. Please consult with a qualified financial professional before making any investment decisions.
About Ingevity Corp
Exchange NYSE | Headquaters North Charleston, SC, United States | ||
IPO Launch date 2016-05-02 | Interim President, Interim CEO & Independent Director Mr. Luis Fernandez-Moreno | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 1600 | Website https://www.ingevity.com |
Full time employees 1600 | Website https://www.ingevity.com |
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.